An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.
Several professionals stated the demand for retatrutide could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the British medical regulations.
Some content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.
Service Reaction and Material Elimination
Based on TikTok, the service has removed problematic content and prohibited associated hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Online Trading Operations
Investigations also found communities with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.
Within minutes of entering one community, a seller shared contact information, where the majority of transactions occur. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, medical conditions or previous experience.
Item Information and Costs
Inside these communities, posts show dark colored parcels with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A representative for the messaging service said it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting materials they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her staff has previously seen individuals injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company investigational product not yet approved … may expose patients to potentially significant health risks”.
